These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 12686496
21. Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans. Klieber S, Hugla S, Ngo R, Arabeyre-Fabre C, Meunier V, Sadoun F, Fedeli O, Rival M, Bourrie M, Guillou F, Maurel P, Fabre G. Drug Metab Dispos; 2008 May; 36(5):851-62. PubMed ID: 18256203 [Abstract] [Full Text] [Related]
22. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches. Stevens JC, Fayer JL, Cassidy KC. Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497 [Abstract] [Full Text] [Related]
23. [Advances in study of metabolic activation of carboxyl-acid containing drugs by UGTs]. Xie T, Liang Y, Hao HP, Xie L, Wang GJ. Yao Xue Xue Bao; 2009 Nov; 44(11):1193-9. PubMed ID: 21355318 [Abstract] [Full Text] [Related]
24. Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Trottier J, Verreault M, Grepper S, Monté D, Bélanger J, Kaeding J, Caron P, Inaba TT, Barbier O. Hepatology; 2006 Nov; 44(5):1158-70. PubMed ID: 17058234 [Abstract] [Full Text] [Related]
25. Activated phase II metabolites: comparison of alkylation by 1-O-acyl glucuronides and acyl sulfates. van Breemen RB, Fenselau CC, Dulik DM. Adv Exp Med Biol; 1986 Nov; 197():423-9. PubMed ID: 3094339 [Abstract] [Full Text] [Related]
26. Glucuronidation: driving factors and their impact on glucuronide disposition. Yang G, Ge S, Singh R, Basu S, Shatzer K, Zen M, Liu J, Tu Y, Zhang C, Wei J, Shi J, Zhu L, Liu Z, Wang Y, Gao S, Hu M. Drug Metab Rev; 2017 May; 49(2):105-138. PubMed ID: 28266877 [Abstract] [Full Text] [Related]
34. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes. Yamanaka H, Nakajima M, Katoh M, Kanoh A, Tamura O, Ishibashi H, Yokoi T. Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160 [Abstract] [Full Text] [Related]
35. Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. Meffin PJ, Zilm DM, Veenendaal JR. J Pharmacol Exp Ther; 1983 Dec; 227(3):732-8. PubMed ID: 6655566 [Abstract] [Full Text] [Related]
36. Biosynthesis of Drug Glucuronide Metabolites in the Budding Yeast Saccharomyces cerevisiae. Ikushiro S, Nishikawa M, Masuyama Y, Shouji T, Fujii M, Hamada M, Nakajima N, Finel M, Yasuda K, Kamakura M, Sakaki T. Mol Pharm; 2016 Jul 05; 13(7):2274-82. PubMed ID: 27241161 [Abstract] [Full Text] [Related]